Results
3042
Most Popular Stocks on the market
3042 companies
China Animal Husbandry Industry
Market Cap: CN¥7.2b
Researches, develops, produces, and sells animal health and nutrition products in China and internationally.
600195
CN¥7.06
7D
-2.2%
1Y
6.8%
Hunan Er-Kang Pharmaceutical
Market Cap: CN¥7.2b
Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.
300267
CN¥3.49
7D
-4.4%
1Y
38.5%
Cronos Group
Market Cap: CA$1.4b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$3.65
7D
1.4%
1Y
25.0%
Shandong Jincheng Pharmaceutical Group
Market Cap: CN¥7.2b
Researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally.
300233
CN¥18.91
7D
-6.3%
1Y
51.0%
Genomma Lab Internacional. de
Market Cap: Mex$18.4b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$18.85
7D
-7.8%
1Y
-15.8%
Shandong Boan Biotechnology
Market Cap: HK$7.8b
A biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China.
6955
HK$12.54
7D
-10.2%
1Y
29.3%
YD Bio
Market Cap: US$1.0b
A biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs.
YDES
US$16.00
7D
-19.1%
1Y
42.1%
Jiangsu Jibeier Pharmaceutical
Market Cap: CN¥7.1b
A pharmaceutical company, engages in the research, development, production, and sale of chemical pharmaceutical preparations, Chinese medicine, and drugs.
688566
CN¥35.40
7D
-1.8%
1Y
60.9%
Towa Pharmaceutical
Market Cap: JP¥147.7b
Manufactures and sale ethical drugs in Japan.
4553
JP¥3,000.00
7D
0.9%
1Y
-2.1%
Hainan Haiyao
Market Cap: CN¥7.0b
Manufactures and sells pharmaceutical products and medical devices in China and internationally.
000566
CN¥5.40
7D
-8.2%
1Y
37.4%
PolyPeptide Group
Market Cap: CHF 781.9m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 23.70
7D
-7.8%
1Y
-25.4%
Maccura BiotechnologyLtd
Market Cap: CN¥7.0b
Engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally.
300463
CN¥11.57
7D
-1.8%
1Y
-10.0%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥7.0b
Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China.
002437
CN¥3.11
7D
-7.4%
1Y
51.0%
Gubra
Market Cap: DKK 6.2b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 381.20
7D
-10.5%
1Y
-21.7%
Kaken Pharmaceutical
Market Cap: JP¥146.2b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,860.00
7D
0%
1Y
0.3%
Shouyao Holdings (Beijing)
Market Cap: CN¥6.9b
Engages in the research, development, and production of pharmaceutical drugs in China.
688197
CN¥46.22
7D
0.7%
1Y
35.5%
Idorsia
Market Cap: CHF 763.0m
A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.
IDIA
CHF 3.65
7D
-9.6%
1Y
128.0%
Chongqing Pharscin Pharmaceutical
Market Cap: CN¥6.8b
Chongqing Pharscin Pharmaceutical Co., Ltd.
002907
CN¥16.29
7D
-2.6%
1Y
25.4%
Wanbangde Pharmaceutical Holding Group
Market Cap: CN¥6.8b
Wanbangde Pharmaceutical Holding Group Co., Ltd.
002082
CN¥11.08
7D
-2.1%
1Y
143.5%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.4b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.81
7D
-2.1%
1Y
2.4%
Spyre Therapeutics
Market Cap: US$942.9m
A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).
SYRE
US$16.24
7D
9.1%
1Y
-43.0%
ARS Pharmaceuticals
Market Cap: US$942.8m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$9.80
7D
0.1%
1Y
-31.6%
Jacobio Pharmaceuticals Group
Market Cap: HK$7.3b
An investment holding company, engages in the in-house discovery and development of oncology therapies.
1167
HK$9.24
7D
-12.7%
1Y
402.2%
Polaris Group
Market Cap: NT$28.6b
Offers biotechnology, drug testing, and contract development and manufacturing services.
6550
NT$37.10
7D
0%
1Y
-32.3%
Shanghai InnoStar Bio-tech
Market Cap: CN¥6.7b
Provides drug research and development services in China and internationally.
688710
CN¥47.39
7D
-3.6%
1Y
78.1%
Saudi Pharmaceutical Industries and Medical Appliances
Market Cap: ر.س3.5b
Develops, manufactures, and markets of medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middles East, Egypt, and Morocco.
2070
ر.س29.10
7D
4.3%
1Y
-14.8%
Nanjing Hicin Pharmaceutical
Market Cap: CN¥6.6b
Engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates.
300584
CN¥55.31
7D
-8.5%
1Y
173.8%
Bide Pharmatech
Market Cap: CN¥6.6b
Engages in the research, development, production, and sale of pharmaceutical products in China.
688073
CN¥76.90
7D
10.0%
1Y
136.1%
NatureCellLtd
Market Cap: ₩1.3t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩20,200.00
7D
-3.6%
1Y
108.0%
Oculis Holding
Market Cap: US$915.9m
A clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.
OCS
US$17.63
7D
6.1%
1Y
43.2%
Shanxi Zhendong PharmaceuticalLtd
Market Cap: CN¥6.5b
Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally.
300158
CN¥6.57
7D
-10.7%
1Y
69.3%
Clarity Pharmaceuticals
Market Cap: AU$1.4b
A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States.
CU6
AU$3.76
7D
0.5%
1Y
-56.5%
EyePoint Pharmaceuticals
Market Cap: US$909.2m
Engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
EYPT
US$13.90
7D
4.9%
1Y
74.2%
MedCap
Market Cap: SEK 8.5b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 568.00
7D
-6.4%
1Y
12.7%
Guizhou Xinbang Pharmaceutical
Market Cap: CN¥6.5b
Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.
002390
CN¥3.42
7D
-3.1%
1Y
0.6%
Center Laboratories
Market Cap: NT$27.6b
A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.
4123
NT$38.85
7D
-1.6%
1Y
-20.7%